Luteal phase clomiphene citrate for ovulation induction in women with polycystic ovary syndrome: a systematic review and meta-analysis

Gynecological Endocrinology

Volumn 32, Issue 11, 2016, Pages 866-871

  Ding, Nan ^a   Chang, Jianbo ^a   Jian, Qiliang ^a   Liang, Xuefei ^a   Liang, Zhongzhen ^a   Wang, Fang ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

Clomiphene citrate; meta analysis; ovulation induction; polycystic ovary syndrome; randomized controlled trial

Indexed keywords

CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; CLOMIFENE; FERTILITY PROMOTING AGENT;

ABORTION; DRUG EFFICACY; ENDOMETRIAL THICKNESS; FOLLICULAR PHASE; HUMAN; LUTEAL PHASE; META ANALYSIS; OVARY FOLLICLE; OVARY POLYCYSTIC DISEASE; OVULATION; OVULATION INDUCTION; PREGNANCY RATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SPONTANEOUS ABORTION; SYSTEMATIC REVIEW; COMPLICATION; DRUG EFFECTS; FEMALE; INFERTILITY, FEMALE; PROCEDURES;

CLOMIPHENE; FEMALE; FERTILITY AGENTS, FEMALE; HUMANS; INFERTILITY, FEMALE; LUTEAL PHASE; OVULATION INDUCTION; POLYCYSTIC OVARY SYNDROME;

EID: 85003034260     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590.2016.1197196     Document Type: Review

References (23)

1. Tarlatzis BC, Fauser BC, Legro RS, et al. Consensus on infertility treatment related to polycystic ovary syndrome. Human Reprod 2008;23:462–77.
2. Abu Hashim H., Clomiphene citrate alternatives for the initial management of polycystic ovary syndrome:an evidence-based approach. Arch Gynecol Obstet 2012;285:1737–45.
3. Palomba S, Russo T, Orio F, Jr., et al. Uterine effects of clomiphene citrate in women with polycystic ovary syndrome:a prospective controlled study. Human Reprod 2006;21:2823–9.
4. Fields E, Chard J, James D, Treasure T., Fertility (update):summary of NICE guidance. BMJ 2013;346:f650
5. Greenblatt RB, Barfield WE, Jungck EC, Ray AW., Induction of ovulation with MRL/41. Preliminary report. JAMA 1961;178:101–4.
6. Thompson LA, Barratt CL, Thornton SJ, et al. The effects of clomiphene citrate and cyclofenil on cervical mucus volume and receptivity over the periovulatory period. Fertil Steril 1993;59:125–9.
7. Speroff L, Glass RH, Kase NG, editors. Clinical gynecologic endocrinology and infertility. Baltimore (MD):Lippincott, Williams & Wilkins; 1999:487–522.
8. Kelekci S, Saygili-Yilmaz E, Inan I, Eminsoy G., A trial of a new regimen with clomiphene citrate administration to reduce the antiestrogenic effects on reproductive end organs. Eur J Obstet Gynecol Reprod Biol 2004;116:54–7.
9. Biljan MM, Mahutte NG, Tulandi T, Tan SL., Prospective randomized double-blind trial of the correlation between time of administration and antiestrogenic effects of clomiphene citrate on reproductive end organs. Fertil Steril 1999;71:633–8.
10. Badawy A, Inany H, Mosbah A, Abulatta M., Luteal phase clomiphene citrate for ovulation induction in women with polycystic ovary syndrome:a novel protocol. Fertil Steril 2009;91:838–41.
11. Moher D, Liberati A, Tetzlaff J, Altman DG., Preferred reporting items for systematic reviews and meta-analyses:the PRISMA statement. J Clin Epidemiol 2009;62:1006–12.
12. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reprod 2004;19:41–7.
13. Higgins JP, Green S., Cochrane handbook for systematic reviews of interventions (Version 5.1.0). Available from:http://www.cochrane-handbook.org [last accessed 5 Jan 2012]
14. Elguindy AHM, El-Shamy R., Early clomiphene citrate for induction of ovulation in women with polycystic ovary syndrome a randomized controlled trial. J Am Sci 2013;9:418–22.
15. Eid SMSMM., Effect of late luteal phase clomiphene citrate on ovulation induction and endometrial blood flow in patients with polycystic ovary syndrome. Clin Med Diagn 2014;4:65–70.
16. Kosar O, Ozaksit G, Taskin MI., Luteal phase clomiphene citrate for ovulation induction in women with polycystic ovary syndrome. Arch Gynecol Obstet 2014;290:771–5.
17. Nahuis MJ, Weiss NS, van der Veen F, et al. The M-OVIN study:does switching treatment to FSH and/or IUI lead to higher pregnancy rates in a subset of women with world health organization type II anovulation not conceiving after six ovulatory cycles with clomiphene citrate–a randomised controlled trial. BMC Women's Health 2013;13:42.
18. Guzick DS., Ovulation induction management of PCOS. Clin Obstet Gynecol 2007;50:255–67.
19. Marrs RP, Vargyas JM, Shangold GM, Yee B., The effect of time of initiation of clomiphene citrate on multiple follicle development for human in vitro fertilization and embryo replacement procedures. Fertil Steril 1984;41:682–5.
20. Dehbashi S, Vafaei H, Parsanezhad MD, Alborzi S., Time of initiation of clomiphene citrate and pregnancy rate in polycystic ovarian syndrome. Int J Gynaecol Obstet 2006;93:44–8.
21. Baerwald AR, Adams GP, Pierson RA., Ovarian antral folliculogenesis during the human menstrual cycle:a review. Human Reprod Update 2012;18:73–91.
22. Palomba S., Aromatase inhibitors for ovulation induction. J Clin Endocrinol Metab 2015;100:1742–7.
23. Markiewicz L, Laufer N, Gurpide E., In vitro effects of clomiphene citrate on human endometrium. Fertil Steril 1988;50:772–6.